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Abstract
Background: Intestinal bacteria are thought to play a role in the pathogenesis of human inflammatory bowel
disease (IBD). We investigated whether oral inoculation with specific intestinal bacteria increased colon
inflammation in the multi-drug resistance 1a-deficient (Mdr1a–/–) mouse model of IBD.
Methods: Five-week-old Mdr1a–/– mice (FVB background) and FVB mice were randomly assigned to one of two
treatment groups (Control or Inoculation, n = 12 per group). All mice were fed AIN-76A rodent diet, and mice in
the Inoculation groups also received a single oral bacterial inoculation consisting of twelve cultured Enterococcus
species combined with conventional intestinal flora obtained from the gastrointestinal tract of healthy mice (EF.CIF).
Body weight, food intake, and disease activity index (DAI) were assessed throughout the study, and at 21 or 24
weeks of age, inflammation was assessed post-mortem by determining colon length and histological injury score
(HIS), and plasma serum amyloid A (SAA).
Results: Mdr1a–/– mice consumed more food than FVB mice at 13 weeks of age (P < 0.05). There was also a
significant effect of genotype on body weight, with Mdr1a–/– mice weighing less than FVB mice throughout the
study (P < 0.05) regardless of treatment, but there was no effect of inoculation on body weight (P > 0.25). Colon
HIS of Mdr1a–/– mice was significantly higher than that of FVB mice in the Control (9.3 ± 4.7 (mean ± SD) vs.
0.58 ± 0.51; P < 0.001) and Inoculation (6.7 ± 5.1 vs. 0.92 ± 0.39; P < 0.001) groups. There was no difference in
colon HIS of Mdr1a–/– mice in the Control group compared with Mdr1a–/– mice in the Inoculation group (P = 0.25),
nor was there any difference in within-group variation of colon HIS in these two Mdr1a–/– groups. DAI was higher
in Mdr1a–/– mice than in FVB mice, but there was no effect of treatment in either strain, nor were there any
differences in colon length or plasma SAA.
Conclusions: Inoculation of Mdr1a–/– mice with the EF.CIF inoculum described here does not increase colon
inflammation or reduce the observed variability of inflammation.
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Background
Crohn’s disease (CD) and ulcerative colitis (UC) are col-
lectively known as inflammatory bowel disease (IBD),
and are characterised by chronic inflammation of the
gastrointestinal (GI) tract. Although the aetiology of IBD
is still not clear, there is strong evidence to suggest that
dysregulated mucosal immune responses to commensal
intestinal microbiota in genetically susceptible individ-
uals are a key factor [1].
Small animal models of intestinal inflammation are
useful to better characterize the mechanisms underlying
human IBD. The multi-drug resistance 1a (Mdr1a) gene
(also known as the Abcb1a gene) encodes a membrane
drug-efflux pump that is expressed in intestinal epithelial
cells, as well as in other cell types. The disruption of this
gene in Mdr1a–/– mice results in spontaneous inflamma-
tion in the colon which exhibits a pathology similar to
that of human IBD [2], making them a relevant and ap-
propriate animal model with which to study IBD [3].
However, ours and other studies with this mouse model
have shown that the time of onset and severity of in-
flammation in Mdr1a–/– mice are variable [2, 4].
We have previously used oral bacterial inoculation with
Enterococcus species and intestinal flora from convention-
ally raised mice (collectively referred to as EF.CIF) to es-
tablish more consistent inflammation in the interleukin 10
gene-deficient (Il10–/–) mouse model of IBD [5]. Because
there is evidence that commensal bacteria play a role in
the intestinal inflammation seen in Mdr1a–/– mice [6, 7],
in the current study the hypothesis that oral inoculation
with the EF.CIF inoculum could induce increased and/or
more consistent inflammation in Mdr1a–/– mice was
tested.
Methods
This study was carried out in accordance with the rec-
ommendations of the New Zealand Animal Welfare Act
1999. The experimental procedures for this study were
reviewed and approved by the AgResearch Grasslands
Animal Ethics Committee in Palmerston North, New
Zealand (Ethics Application No.: 10712). All efforts were
made to minimize animal suffering.
Animals and diet
This study was part of a larger investigation on the ef-
fects of dietary polyphenols in the Mdr1a–/– mouse
model of IBD (see Additional file 1). The “Control”
groups for both Mdr1a–/– and FVB mice were therefore
used as dietary controls for the previously reported in-
vestigations of dietary polyphenols [6, 8]. For this study
on the effects of bacterial inoculation, twenty-four male
Mdr1a–/– mice (FVB.129P2-PAbcb1atm1Bor N7) and 24
male FVB/NTac mice (subsequently referred to as FVB
mice, with the same background strain as the Mdr1a–/–
mice) were purchased from Taconic (Hudson, NY, USA)
at 5-6 weeks of age. The mice were individually housed
in shoebox-style cages containing untreated wood shav-
ings (Cairns Bins, Palmerston North, New Zealand
(NZ)) with a plastic tube for environmental enrichment.
The animal room was controlled and maintained at a
temperature of 22 °C, humidity of 60 % and a 12/12 h
light/dark cycle. All mice were given free access to water
and offered a standard chow diet ad libitum. After 1
week of acclimatization on this chow diet (i.e., at ap-
proximately 7 weeks of age), both Mdr1a–/– and FVB
mice were randomly assigned to one of two intervention
groups (n = 12 per group); an AIN-76A powdered diet
prepared in-house as previously described [4] (Control
group); or the AIN-76A diet + a single oral inoculation
with 200 μL of a mixture of Enterococcus faecalis and E.
faecium cultures plus complex intestinal flora (collect-
ively referred to as EF.CIF; Inoculation group) [5]. Each
mouse received a dose of approximately 6 x 107 CFU
from the Enterococcus cultures. Details of the bacterial
inoculation protocol, and information regarding the
twelve Enterococcus strains used (which were exactly the
same as in our previous studies using Il10–/– mice), have
already been reported [5]. Fresh diets were fed ad
libitum and food consumption was recorded in week 8
(14–15 weeks of age) and week 11 (17–18 weeks of age)
of the intervention period to measure the average food
intake. Mice were weighed three times a week and visu-
ally checked daily for the presence of loose stools, blood
in faeces, or decreased mobility (the disease activity
index; DAI) which has been reported to correlate with
intestinal inflammation [9]. DAI data were recorded at
least once a week, and a total DAI score at each time
was calculated for each mouse based on the combined
scores of weight loss, stool consistency, rectal bleeding
and mobility (each ranging from 0 to 4), divided by 4.
Sample collection
At 21 or 24 weeks of age, mice were euthanized by CO2
asphyxiation and cervical dislocation for tissue sampling
(see Table 1 for final numbers of mice per group). These
sampling times were chosen to ensure that the majority
of Mdr1a–/– mice had developed colonic inflammation;
as already mentioned, inter-animal variation in the time
of onset of inflammation has been observed [4]. On the
day before tissue sampling (at either 21 or 24 weeks of
age), to minimise the variation between the last meal
and sampling, mice were fasted overnight and food was
returned the following morning for 2 h before sampling
in staggered groups [10]. Blood was sampled via cardiac
puncture (0.5 to 1 mL), cells pelleted and the plasma
snap-frozen and stored at -85 °C for subsequent serum
amyloid A (SAA) analysis. The colon was then quickly
removed, cut open lengthwise and flushed with 0.9 %
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NaCl to remove any trace of digesta. The colon length
was measured, and the proximal half of the colon was
then cut into two pieces, one of which was used for
histological evaluation (stored at room temperature in
10 % neutral buffered formalin).
Histology
Colon inflammation was assessed according to criteria
which have previously been described in detail [4, 11].
Briefly, formalin-fixed colon tissue samples were proc-
essed and sectioned (4 μm), stained with haematoxylin
and eosin, and assessed under a light microscope by one
researcher blinded to the treatments. Each section was
evaluated for the presence of inflammatory lesions, tis-
sue destruction, and tissue repair, and a histological in-
jury score (HIS) assigned based on this evaluation.
Serum amyloid A analysis
The level of serum amyloid A (SAA) in plasma of
Mdr1a–/– mice was measured to assess systemic inflam-
mation levels and to complement the colonic HIS data.
Ten μL of plasma (diluted 1:5000) was used to measure
the plasma concentration of SAA using the Serum Amyl-
oid A kit (Tridelta Development Limited, Maynooth,
County Kildare, Ireland) as described by the manufacturer.
Statistical analysis
Unless otherwise stated data are presented as mean ±
standard deviation. Statistical analyses of body weight,
food intake, histology, total DAI, and SAA data were by
ANOVA using GenStat for Windows (version 17, VSN
International Ltd, UK). The colon HIS data were log
transformed as log10(Colon HIS + 0.5) and SAA as
log10(SAA + 0.005) for analysis, to stabilize the variance.
DAI data over time were analysed using a repeated
measures ANOVA which applies a Greenhouse-Geisser
adjustment (GenStat v17). Correlation analyses (Pearson
product–moment correlation) to investigate the relation-
ship between colon HIS and body weight were
performed using R version 3.0.1.
Results
Animal food intake, body weight, and disease activity
index
The mean food intake at 15 weeks of age in Mdr1a–/–
mice was significantly (P = 0.03) higher than that of FVB
mice (Table 1). There were no significant strain differ-
ences in mean food intake at 18 weeks of age, and there
was no effect of intervention (Control vs. Inoculation) at
either 15 or 18 weeks (Table 1).
Mdr1a–/– mice weighed less than FVB mice through-
out the study regardless of treatment (Table 1). There
was no effect of inoculation on body weight for either
Mdr1a–/– or FVB mice (P > 0.25; Table 1).
DAI over time, and mean total DAI, were higher in
Mdr1a–/– mice than in FVB mice (P < 0.001). Mean
total DAI in the Control Mdr1a–/– mice (0.13 ± 0.14)
was higher than that in Control FVB mice (0.05 ± 0.04),
and the same pattern was seen in animals from the Inocu-
lation groups (Mdr1a–/– 0.12 ± 0.12 vs. FVB 0.03 ± 0.03).
There was no significant effect of inoculation on mean
total DAI (P = 0.8).
Table 1 Food intake and body weight data for FVB and Mdr1a–/− mice fed an AIN-76A diet (Control), or fed an AIN-76A diet and







(15 weeks of age)
Food intakeb
(18 weeks of age)
Body weight (7 weeks of
age; start of intervention)c
Body weight (19 weeks




(21 or 24 weeks of age)
FVB mice
Control 12 (12) 4.5 ± 0.8 4.7 ± 0.5 24.8 ± 1.6 37.1 ± 5.3 34.4 ± 6.0
Inoculation 12 (12) 4.4 ± 0.6 4.7 ± 0.4 24.7 ± 1.1 37.6 ± 2.5 36.0 ± 4.0
Mdr1a–/– mice
Controle 12 (8) 4.7 ± 0.2 4.3 ± 1.0 23.6 ± 1.5 30.8 ± 4.3 28.2 ± 4.5
Inoculation 12 (10) 4.8 ± 0.4 4.5 ± 0.5 23.3 ± 1.6 31.4 ± 4.3 28.6 ± 5.0
aEach group had n = 12 mice at the start of the study. In both of the Mdr1a–/– groups some mice either died during the study, or samples were not successfully
obtained from these animals, resulting in a reduced number of observations at the end of the study, as shown here. Necropsy was unable to identify a cause of
death in any of these cases. These animals were therefore excluded from analyses
bFood intake of all individual mice was measured for two periods of 4 days duration (at age 14-15 and 17-18 weeks). Data are shown as the mean food intake ± SD per
group of mice (g per day). Statistically significant differences are described in the results section
cBody weight was measured three times a week. Body weight at the start of the intervention, and after 12 weeks of intervention, is presented here as mean ± SD
per group of mice (g). Statistically significant differences are described in the results section
dBody weight was also measured on the day of sampling, after an overnight fast. Mice were either sampled at 21 weeks (sampling group 1) or 24 weeks of age
(sampling group 2). For simplicity, combined data from both sampling groups are shown here as the mean ± SD (g). Statistically significant differences are
described in the results section
eBecause the inoculation experiment formed part of a larger study (Additional file 1) investigating the effects of dietary polyphenols on colon inflammation [6, 8],
data for Mdr1a–/– mice fed the AIN-76A diet (apart from body weight at 19 weeks of age) have already been reported [6]. However, these data are included here
for completeness
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Colon length and histology, and plasma serum amyloid A
There were no significant differences in colon length on
the basis of either strain or treatment (Control Mdr1a–/–
mice 7.2 ± 0.5 cm; Inoculation Mdr1a–/– mice 7.0 ± 0.6
cm; Control FVB mice 7.1 ± 0.7 cm; Inoculation FVB
mice 7.3 ± 0.9 cm; P > 0.2 for all comparisons). Colon
HIS of Mdr1a–/– mice in the Control group (9.3 ± 4.7)
was significantly higher than that of FVB mice in the
Control group (0.6 ± 0.5; P < 0.001). Similarly, colon HIS
of Mdr1a–/– mice in the Inoculation group (6.7 ± 5.1) was
significantly higher than for FVB mice in the Inoculation
group (0.9 ± 0.5; P < 0.001). There was no significant dif-
ference (P = 0.25) between the average colon HIS of
Mdr1a–/– mice in the Control group compared with
Mdr1a–/– mice in the Inoculation group (Fig. 1). Further-
more, inoculation did not result in more consistent
inflammation in Mdr1a–/– mice; SD of colon HIS was
similar in the Control (4.7) and Inoculation (5.1) Mdr1a–/–
mice. None of the FVB mice showed evidence of inflam-
mation with colon HIS values of 2 or less. Representative
images of H&E stained sections used for histological
analysis are shown in Fig. 2.
There was no significant effect of inoculation on
mean plasma levels of SAA in Mdr1a–/– mice (Inoculated
mice 0.39 ± 0.72 μg/ml vs. Control mice 0.51 ± 0.66 μg/ml;
P = 0.5).
Correlations between colon HIS and body weight
There was only weak evidence of a negative correlation
between colon HIS and measures of body weight. For
example, the strongest correlation in Mdr1a–/– Control
mice was between colon HIS and body weight change
between 7 and 21 weeks of age (Pearson’s r = -0.40,
P = 0.07; Fig. 3a), whereas for Mdr1a–/– Inoculation
mice the strongest correlation was between colon HIS and
fasted body weight prior to sampling (Pearson’s r = -0.40,
P = 0.26; Fig. 3b). There was no evidence of a correlation
between colon HIS and colon length, or between colon
HIS and DAI (data not shown).
Discussion
Oral inoculation with the mixture of intestinal bacteria in-
cluding Enterococcus isolates described here (EF.CIF) has
previously been shown to increase colon inflammation in
Il10–/– mice [5], but this particular inoculum was not ef-


































Fig. 1 Histological injury score (HIS) of colon tissue samples. Samples
were collected from FVB and Mdr1a–/– mice which were fed an AIN-
76A (Control) diet, or were fed an AIN-76A diet and received a single
dose (via oral inoculation) of a mixture of Enterococcus faecalis and E.
faecium cultures and complex intestinal flora (EF.CIF; Inoculation). Data
are shown as the values for individual mice (×) and as the overall mean
(closed circle, FVB mice; open circle; Mdr1a–/–) for each group; data
from individual samples collected at 21 weeks of age are shown to the
left, and data from samples collected at 24 weeks of age are shown to
the right, of the respective means. The number of mice in each group
is reported in Table 1. Values for the mean ± SD are reported in
the results
Fig. 2 Representative H&E stained sections of mouse colon tissue
samples from which histological injury score (HIS) was assessed.
Micrographs represent samples from each of the treatment groups.
Mice in the Control groups were fed an AIN-76A diet, while those in
the Inoculation groups were fed AIN-76A diet and received a single
oral inoculation of a mixture of Enterococcus faecalis and E. faecium
cultures and complex intestinal flora (CIF) derived from FVB/N mice
raised under conventional conditions (EF.CIF). In panel a (FVB Control),
there is no evidence of inflammation. In panel b (FVB Inoculation),
there is evidence of minimal and focal inflammatory cell infiltrates in
the mucosa (as indicated by “in”) with an intact epithelial layer.
Panels a and b are typical of FVB mice in both the Control and
Inoculation groups. In panel c (Mdr1a–/– Control), there is severe
mucosal, submucosal and transmural inflammation and damage to the
tissue architecture, with little or no normal tissue remaining; there are
also crypt abscesses (indicated by “ab”), and clusters of infiltrating
monocytes (“m”). Panel d (Mdr1a–/– Inoculation) shows diffuse
inflammatory cell infiltrates in the mucosa and submucosa (as
indicated by “in”) with erosions and distorted villous structure;
although there are still some crypts (“c”), these are irregular. Panels c
and d are typical of Mdr1a–/– mice in both the Control and Inoculation
groups. All images were captured at 10× magnification
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factors, including (1) the particular strains of enterococci
used, (2) differences in the pathways of inflammation be-
tween the two mouse models, (3) differences in the back-
ground mouse strain used, or (4) because the effects of
specific bacterial strains or bacterial-associated antigens
may be dependent on the genetic basis of the inflamma-
tion [3]. For example, infection of Mdr1a–/– mice with
Helicobacter bilis has been shown to accelerate the onset
of colitis, whereas infection with H. hepaticus delayed col-
itis development [12]. In contrast, both of these
Helicobacter isolates have repeatedly induced severe in-
flammation in Il10–/– mice [13]. Likewise, although the
EF.CIF inoculum used in the current study increased
colon inflammation in Il10–/– mice [5], different strains of
enterococci show varying effects in this mouse model. For
example, treatment of Il10–/– mice with E. faecium
NCIMB 10415 (which reduces diarrhoea in animals and
in human study subjects) led to a moderate reduction of
inflammation in the caecum, but had no effect on the
colon [14]. In contrast, the E. faecalis strain OG1RF is
A
B
Fig. 3 Assessment of correlations between colon HIS and measures of body weight. To investigate the relationship between colon HIS and body
weight, Pearson’s product–moment correlation analyses were performed using R version 3.0.1. There were no significant correlations observed
between colon HIS and any measure of body weight using this analysis. Panel a shows the strongest correlation found for the Mdr1a–/– Control
group, which was that between colon HIS and change in body weight from 7 to 21 weeks of age (R = -0.40, P = 0.07), while panel b
shows the strongest correlation found for the Mdr1a–/– Inoculation group, which was between colon HIS and fasted body weight prior to
sampling (R = -0.40, P = 0.26)
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colitogenic, and production of a metalloprotease, GelE, by
this strain appears to impair epithelial barrier integrity,
thereby contributing to inflammation, in Il10–/– mice [15].
Finally, we are aware that the FVB/NJ mouse strain fails
to secrete complement 5 [16], a factor known to exacer-
bate IBD in the dextran-sulfate sodium (DSS) model [17],
and is thus partially immunocompromised. Because the
Mdr1a–/– mutation was on the FVB strain, this may in
part explain the lack of response in this experiment when
compared with prior studies using the same inoculation
protocol in the Il10–/– mouse model, which were on a
C57Bl/6 background. Furthermore, in our original study
in which we reported the effect of inoculation in Il10–/–
mice, there was little evidence of inflammation in the
absence of inoculation [5, 11], whereas in our original
Mdr1a–/– mouse study there was clear evidence of in-
flammation in un-inoculated mice, although the level
was variable [4]. This suggests that the involvement of
bacteria is critical for triggering inflammation in Il10–/–
mice but not in the Mdr1a–/– mouse.
In the absence of any data on the intestinal microbial
populations in the current study it is not possible to
draw any conclusions on the role of these populations in
inflammation. However, we have previously suggested
that in Il10–/– mice, inoculation with exogenous bacteria
triggers the immune response and consequently inflam-
mation, which is followed by dysbiosis which may act to
perpetuate and amplify the inflammatory response [18].
It is tempting to speculate that in Mdr1a–/– mice some
degree of dysbiosis is already present, thus limiting any
effect of the introduction of additional bacteria. Obvi-
ously additional experiments in which intestinal micro-
bial populations are assessed would be necessary to
confirm this suggestion.
The lack of correlation between colon HIS and body
weight in Mdr1a–/– mice (in either the Control or
Inoculation groups) suggests that the reduced body
weight observed in Mdr1a–/– mice is at least in part due
to a metabolic alteration, rather than being entirely to
disease severity per se.
One potentially important limitation of the current
study is the lack of a positive control (for example, the
inclusion of a group of Il10–/– mice) to demonstrate that
the inoculation per se was effective. While this type of
control would be appropriate for any future studies, we
do not consider it practicable to repeat the experiment
with such a control. However, we are confident that in
this case the bacteria (at least the Enterococcus isolates)
were viable when administered. To assess the colony
forming units within the volume of inoculum adminis-
tered to each mouse, each Enterococcus isolate was cul-
tured on appropriate media. Each sub-sample for this
assessment was taken from the respective Enterococcus
culture used for inoculation at the time that the inoculum
was administered. In all twelve cases, the cultures grew
successfully, which we believe demonstrates that the bac-
teria were viable when administered to the mice. Although
we do not have similar information for the CIF compo-
nent of the inoculum, this was prepared as described for
our previously reported Il10–/– mouse studies, in which
we have shown consistent inflammation in response to
this inoculation protocol [11, 19–21].
Conclusions
Inoculation of Mdr1a–/– mice with an EF.CIF inoculum
(which was previously shown to increase inflammation
in Il10–/– mice) did not increase colon inflammation or
reduce the observed variability of inflammation as
assessed by histological and plasma SAA analyses. This
result reflects the complex interactions between the in-
testinal bacterial population and the intestinal epithe-
lium, and the role that the host’s genetic background
may play in these interactions.
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Additional file 1: Representation of the overall investigation of which
this study forms a part. Description of data: a figure showing how this
study of the impact of bacterial inoculation forms part of a larger
investigation into the effects of dietary polyphenols [6, 8] on intestinal
inflammation in the Mdr1a–/– mouse model of IBD. The figure shows
how a common set of control mice was used for the overall
investigation. (PDF 402 kb)
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